Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modeling excess hazard with time-to-cure as a parameter.
Boussari O, Bordes L, Romain G, Colonna M, Bossard N, Remontet L, Jooste V. Boussari O, et al. Biometrics. 2021 Dec;77(4):1289-1302. doi: 10.1111/biom.13361. Epub 2020 Sep 12. Biometrics. 2021. PMID: 32869288
A new approach to estimate time-to-cure from cancer registries data.
Boussari O, Romain G, Remontet L, Bossard N, Mounier M, Bouvier AM, Binquet C, Colonna M, Jooste V. Boussari O, et al. Cancer Epidemiol. 2018 Apr;53:72-80. doi: 10.1016/j.canep.2018.01.013. Epub 2018 Feb 4. Cancer Epidemiol. 2018. PMID: 29414635
Time-to-cure and cure proportion in solid cancers in France. A population based study.
Romain G, Boussari O, Bossard N, Remontet L, Bouvier AM, Mounier M, Iwaz J, Colonna M, Jooste V; French Network of Cancer Registries (FRANCIM). Romain G, et al. Among authors: boussari o. Cancer Epidemiol. 2019 Jun;60:93-101. doi: 10.1016/j.canep.2019.02.006. Epub 2019 Mar 30. Cancer Epidemiol. 2019. PMID: 30933890
Net survival in recurrence-free colon cancer patients.
Drouillard A, Bouvier AM, Boussari O, Romain G, Manfredi S, Lepage C, Faivre J, Jooste V. Drouillard A, et al. Among authors: boussari o. Cancer Epidemiol. 2019 Aug;61:124-128. doi: 10.1016/j.canep.2019.06.001. Epub 2019 Jun 15. Cancer Epidemiol. 2019. PMID: 31212224
Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
Dal Maso L, Panato C, Tavilla A, Guzzinati S, Serraino D, Mallone S, Botta L, Boussari O, Capocaccia R, Colonna M, Crocetti E, Dumas A, Dyba T, Franceschi S, Gatta G, Gigli A, Giusti F, Jooste V, Minicozzi P, Neamtiu L, Romain G, Zorzi M, De Angelis R, Francisci S; EUROCARE-5 Working Group. Dal Maso L, et al. Among authors: boussari o. Int J Epidemiol. 2020 Oct 1;49(5):1517-1525. doi: 10.1093/ije/dyaa128. Int J Epidemiol. 2020. PMID: 32984907
Time trends and short term projections of cancer prevalence in France.
Colonna M, Boussari O, Cowppli-Bony A, Delafosse P, Romain G, Grosclaude P, Jooste V; French Network of Cancer Registries (FRANCIM). Colonna M, et al. Among authors: boussari o. Cancer Epidemiol. 2018 Oct;56:97-105. doi: 10.1016/j.canep.2018.08.001. Epub 2018 Aug 17. Cancer Epidemiol. 2018. PMID: 30125884
Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer.
Guilloteau A, Abrahamowicz M, Boussari O, Jooste V, Aparicio T, Quantin C, Le Malicot K, Binquet C. Guilloteau A, et al. Among authors: boussari o. BMC Med Res Methodol. 2021 Jan 9;21(1):14. doi: 10.1186/s12874-020-01202-9. BMC Med Res Methodol. 2021. PMID: 33422006 Free PMC article. Clinical Trial.
25 results